These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16687088

  • 1. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM, Zhu ZH, Wu QL, Hou JH, Huang XP, Zhang PY, Rong TH.
    Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 3. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 04; 87(45):3228-32. PubMed ID: 18399120
    [Abstract] [Full Text] [Related]

  • 4. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY, Liao ZS, Jiang SP, Zhang W, Li JG, Zheng DH.
    Ai Zheng; 2003 Jan 04; 22(1):86-90. PubMed ID: 12561444
    [Abstract] [Full Text] [Related]

  • 5. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW, Wang L, Zhang XG, Liu MQ.
    Ai Zheng; 2006 Oct 04; 25(10):1238-42. PubMed ID: 17059767
    [Abstract] [Full Text] [Related]

  • 6. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ, Wang J, Li SS, Wu YM, Wu YJ, Wang XC.
    Ai Zheng; 2006 Oct 04; 25(10):1216-20. PubMed ID: 17059763
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 04; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 8. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Zhu ZH, Rong TH, Zeng CG, Wu QL, Ma Y, Huang XP, Li BJ, Zhang PY, Zhao JM, Hu W, Zhang SY, Yu H, Ma GW, Zhang LJ, Wen ZS, Fu JH, Long H.
    Ai Zheng; 2005 Jul 04; 24(7):865-9. PubMed ID: 16004817
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K, Kohnoe S, Watanabe A, Tashiro H, Sakata H, Morita M, Kakeji Y, Maehara Y.
    Oncol Rep; 2009 Feb 04; 21(2):351-5. PubMed ID: 19148507
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    J Clin Oncol; 2005 Jan 20; 23(3):448-54. PubMed ID: 15572731
    [Abstract] [Full Text] [Related]

  • 13. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
    Zheng S, Chang Y, Hodges KB, Sun Y, Ma X, Xue Y, Williamson SR, Lopez-Beltran A, Montironi R, Cheng L.
    Anticancer Res; 2010 Mar 20; 30(3):713-8. PubMed ID: 20392988
    [Abstract] [Full Text] [Related]

  • 14. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 20; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 15. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
    Guo QS, Jia H, Han MY, Yu JM, Zhong WX.
    Zhonghua Zhong Liu Za Zhi; 2006 Oct 20; 28(10):746-9. PubMed ID: 17366785
    [Abstract] [Full Text] [Related]

  • 16. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 20; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 17. [Expression of EYA2 in non-small cell lang cancer].
    Guo JT, Ding LH, Liang CY, Zhou NK, Ye QN.
    Zhonghua Zhong Liu Za Zhi; 2009 Jul 20; 31(7):528-31. PubMed ID: 19950702
    [Abstract] [Full Text] [Related]

  • 18. [Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].
    Qiao GB, Wu YL, Ou W, Yang XN, Zhong WZ, Lin JY, Zhao J, Xie D, Guan XY.
    Zhonghua Wai Ke Za Zhi; 2005 Jul 15; 43(14):913-7. PubMed ID: 16083620
    [Abstract] [Full Text] [Related]

  • 19. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST, Gui SQ, Lin MS.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):580-3. PubMed ID: 17085346
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.